Selected article for: "anti activity and selectivity index"

Author: Baltina, L. A.; Kondratenko, R. M.; Baltina, L. A.; Baschenko, N. Z.; Pl’yasunova, O. A.
Title: Synthesis and biological activity of new glycyrrhizic acid conjugates with amino acids and dipeptides
  • Cord-id: mq944xov
  • Document date: 2009_7_19
  • ID: mq944xov
    Snippet: New glycyrrhizic acid (GA) conjugates were synthesized with the use of tert-butyl esters of amino acids or benzyl esters of dipeptides; they contained two residues of L-amino acids (Met, Phe, Pro, and Ile or dipeptides Gly-Leu and Gly-Phe). Activation of GA carboxy groups was carried out with the help of N-hydroxysuccinimide, N,N′-dicyclohexylcarbodiimide, or N-hydroxybenzotriazole with dicyclohexylcarbodiimide. A proline-containing GA derivative is a low-toxic substance; it raises the level o
    Document: New glycyrrhizic acid (GA) conjugates were synthesized with the use of tert-butyl esters of amino acids or benzyl esters of dipeptides; they contained two residues of L-amino acids (Met, Phe, Pro, and Ile or dipeptides Gly-Leu and Gly-Phe). Activation of GA carboxy groups was carried out with the help of N-hydroxysuccinimide, N,N′-dicyclohexylcarbodiimide, or N-hydroxybenzotriazole with dicyclohexylcarbodiimide. A proline-containing GA derivative is a low-toxic substance; it raises the level of agglutinins by 3.7 times in the blood of mice and 3 times that of hemolysins compared with the control. Dipeptide GA derivatives possess an expressed anti-HIV-1 activity in cultures of MT-4 cells and are 90-70 times less cytotoxic than azidothymidine. The selectivity index of the compounds exceeds those of GA by 110 and 34 times, respectively.

    Search related documents:
    Co phrase search for related documents
    • acid solution and acute toxicity: 1
    • acid solution and low efficiency: 1
    • action mechanism protease and acute infection: 1
    • activity compound and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • activity compound and acute toxicity: 1, 2, 3
    • acute infection and low efficiency: 1, 2
    • acute infection and lymphoid cell: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and low efficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory syndrome and lymphoid cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute toxicity and low efficiency: 1